financetom
Business
financetom
/
Business
/
Tiptree Inc's Q3 revenue up 9.3% on higher earned premiums
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tiptree Inc's Q3 revenue up 9.3% on higher earned premiums
Oct 31, 2025 5:59 AM

Overview

* Tiptree ( TIPT ) Q3 revenue grows 9.3% yr/yr, driven by earned premiums and Fortegra gains

* Net income for Q3 declines due to deal-related expenses and increased liabilities

* Company agrees to sell Fortegra and Reliance First Capital, closing expected in 2026

Outlook

* Company anticipates closing Fortegra sale in mid-2026

* Company expects Reliance First Capital sale to close in Q1 2026

* Tiptree ( TIPT ) focuses on long-term value through strategic investments and cost management

Result Drivers

* EARNED PREMIUMS - Revenue growth driven by increased earned premiums and gains at Fortegra

* DEAL-RELATED EXPENSES - Net income decline attributed to deal-related expenses and increased liabilities

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $540.30

Revenue mln

Q3 EPS $0.13

Q3 $28.76

Adjusted mln

Net

Income

Q3 Net $6.42

Income mln

Analyst Coverage

* The stock recently traded at 40 times the next 12-month earnings vs. a P/E of 53 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Belden Insider Sold Shares Worth $521,119, According to a Recent SEC Filing
Belden Insider Sold Shares Worth $521,119, According to a Recent SEC Filing
Sep 4, 2025
05:42 PM EDT, 09/04/2025 (MT Newswires) -- Brian Lieser, Executive Vice President, Solutions, on September 02, 2025, sold 4,097 shares in Belden (BDC) for $521,119. Following the Form 4 filing with the SEC, Lieser has control over a total of 31,292 common shares of the company, with 30,787 shares held directly and 505 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/913142/000095017025113086/xslF345X05/ownership.xml ...
Campbell's Names Kelly Palumbo as Chief Accounting Officer
Campbell's Names Kelly Palumbo as Chief Accounting Officer
Sep 4, 2025
05:41 PM EDT, 09/04/2025 (MT Newswires) -- Campbell's (CPB) said late Thursday it has appointed Kelly Palumbo as chief accounting officer, starting Sep. 22. Palumbo succeeds Stan Polomski, who has been named senior vice president of Business Process Optimization within the Enterprise Transformation Office, the company said. ...
Zumiez Fiscal Q2 Loss Widens, Net Sales Rise; Shares Advance After Hours
Zumiez Fiscal Q2 Loss Widens, Net Sales Rise; Shares Advance After Hours
Sep 4, 2025
05:41 PM EDT, 09/04/2025 (MT Newswires) -- Zumiez ( ZUMZ ) reported a fiscal Q2 loss late Thursday of $0.06 per diluted share, widening from the $0.04 loss a year earlier. Three analysts polled by FactSet expected a loss of $0.11. Net sales in the three months ended Aug. 2 rose to $214.3 million from $210.2 million a year earlier....
Arrowhead Pharmaceuticals Insider Sold Shares Worth $375,000, According to a Recent SEC Filing
Arrowhead Pharmaceuticals Insider Sold Shares Worth $375,000, According to a Recent SEC Filing
Sep 4, 2025
05:41 PM EDT, 09/04/2025 (MT Newswires) -- James C Hamilton, Chief Medical Officer, on September 02, 2025, sold 15,000 shares in Arrowhead Pharmaceuticals ( ARWR ) for $375,000. Following the Form 4 filing with the SEC, Hamilton has control over a total of 247,122 common shares of the company, with 247,122 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/879407/000183075525000007/xslF345X05/wk-form4_1757021819.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved